Page 34 - Demo

38 PROCEEDINGS OF INTERNATIONAL SCIENTIFIC CONFERENCE ON APPLIED BIOTECHNOLOGY17. Dissection of ESAT-6 System 1 of Mycobacterium Tuberculosis and Impact on Immunogenicity and Virulence | Infection and Immunity Available online: https://journals.asm.org/doi/10.1128/iai.74.1.88-98.2006 (accessed on 7 December 2024).18. Siegrist, M.S.; Steigedal, M.; Ahmad, R.; Mehra, A.; Dragset, M.S.; Schuster, B.M.; Philips, J.A.; Carr, S.A.; Rubin, E.J. Mycobacterial Esx-3 Requires Multiple Components for Iron Acquisition. mBio 2014, 5, 10.1128/mbio.01073-14, doi:10.1128/mbio.01073-14.19. Kirstein, J.; Hoffmann, A.; Lilie, H.; Schmidt, R.; R%u00fcbsamenWaigmann, H.; Br%u00f6tz-Oesterhelt, H.; Mogk, A.; Turgay, K. The Antibiotic ADEP Reprogrammes ClpP, Switching It from a Regulated to an Uncontrolled Protease. EMBO Molecular Medicine 2009, 1, 37%u201349, doi:10.1002/emmm.200900002.20. Schmitt, E.K.; Riwanto, M.; Sambandamurthy, V.; Roggo, S.; Miault, C.; Zwingelstein, C.; Krastel, P.; Noble, C.; Beer, D.; Rao, S.P.S.; et al. The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease. Angewandte Chemie International Edition 2011, 50, 5889%u20135891, doi:10.1002/anie.201101740.21. Vasudevan, D.; Rao, S.P.S.; Noble, C.G. Structural Basis of Mycobacterial Inhibition by Cyclomarin A. Journal of Biological Chemistry 2013, 288, 30883%u201330891, doi:10.1074/jbc.M113.493767.22. Gavrish, E.; Sit, C.S.; Cao, S.; Kandror, O.; Spoering, A.; Peoples, A.; Ling, L.; Fetterman, A.; Hughes, D.; Bissell, A.; et al. Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium Tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2. Chemistry & Biology 2014, 21, 509%u2013518, doi:10.1016/j.chembiol.2014.01.014.